Let’s start up with the current stock price of Adaptive Biotechnologies Corporation (ADPT), which is $19.51 to be very precise. The Stock rose vividly during the last session to $21.29 after opening rate of $21.29 while the lowest price it went was recorded $19.25 before closing at $21.33.Recently in News on January 10, 2022, Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition. Adaptive Biotechnologies Corporation (Nasdaq: ADPT) today reported preliminary, unaudited revenue for the year ended December 31, 2021. Total revenue for the year ended December 31, 2021 is estimated to be in the range of $153 million to $154 million, representing an approximate increase of 56% at the mid-point of the range compared to $98.4 million for the year ended December 31, 2020. You can read further details here
Adaptive Biotechnologies Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $28.92 on 01/03/22, with the lowest value was $19.25 for the same time period, recorded on 01/13/22.
Adaptive Biotechnologies Corporation (ADPT) full year performance was -70.28%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Adaptive Biotechnologies Corporation shares are logging -72.62% during the 52-week period from high price, and -6.20% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $20.80 and $71.25.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 990617 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Adaptive Biotechnologies Corporation (ADPT) recorded performance in the market was -30.47%, having the revenues showcasing -41.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.78B, as it employees total of 622 workers.
Market experts do have their say about Adaptive Biotechnologies Corporation (ADPT)
During the last month, 0 analysts gave the Adaptive Biotechnologies Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 31.68, with a change in the price was noted -12.77. In a similar fashion, Adaptive Biotechnologies Corporation posted a movement of -39.56% for the period of last 100 days, recording 682,170 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ADPT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Adaptive Biotechnologies Corporation (ADPT)
Raw Stochastic average of Adaptive Biotechnologies Corporation in the period of last 50 days is set at 1.42%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.31%. In the last 20 days, the company’s Stochastic %K was 8.43% and its Stochastic %D was recorded 11.21%.
Bearing in mind the latest performance of Adaptive Biotechnologies Corporation, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -30.47%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -46.93%, alongside a downfall of -70.28% for the period of the last 12 months. The shares increased approximately by -16.73% in the 7-day charts and went up by -26.60% in the period of the last 30 days. Common stock shares were lifted by -41.57% during last recorded quarter.